SUPPREMOL
SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
SUPPREMOL
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2002-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.suppremol.com
Total Employee:
10001+
Status:
Active
Contact:
49 89 30 90 50 680
Email Addresses:
[email protected]
Total Funding:
71 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Founder
Investors List
BioMedPartners
BioMedPartners investment in Series D - SuppreMol
MIG
MIG investment in Series D - SuppreMol
Santo Holding
Santo Holding investment in Series D - SuppreMol
FCP Biotech Holding
FCP Biotech Holding investment in Series D - SuppreMol
MIG
MIG investment in Series D - SuppreMol
Bayern Kapital
Bayern Kapital investment in Series C - SuppreMol
Santo Holding
Santo Holding investment in Series C - SuppreMol
BioMedPartners
BioMedPartners investment in Series C - SuppreMol
KfW
KfW investment in Series C - SuppreMol
FCP Biotech Holding
FCP Biotech Holding investment in Series C - SuppreMol
